{
  "id": 19252817,
  "title": "TransMedics: 3 Key Takeaways for Long-Term Investors",
  "url": "https://urgent.news/2026/11/10/transmedics-3-key-takeaways-for-long-term-investors",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-10T00:36:59.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/earnings/takeaways/2026/11/09/transmedics-3-key-takeaways-for-long-term-investors/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "TransMedics reported robust third-quarter 2026 revenue of $203 million, a 41% year-over-year increase, despite a 6% decline in U.S. donor organ availability. CEO Waleed Hassanein highlighted two key growth initiatives: expanding enrollment in ENHANCE heart and DENOVO lung clinical programs, which could add 2,000 to 5,000 annual U.S. heart and lung cases, and developing a portable kidney system for kidneys discarded due to prolonged ischemia. Hassanein expressed strong momentum, driven by hospital adoption and global expansion, with all-time high case volumes and operating leverage expected from next-generation organ preservation systems.",
  "summary": "Its ENHANCE heart and DENOVO lung programs target thousands of procedures that currently use no machine preservation at all.",
  "key_points": [
    "TransMedics revenue grew 41% YoY to $203 million in Q3 2026",
    "CEO Waleed Hassanein focuses on ENHANCE and DENOVO clinical programs",
    "Portable kidney system development for discarded kidneys"
  ],
  "editors_take": "Expanding clinical programs and new kidney technology positions the company to decouple revenue growth from declining organ availability by capturing more transplant cases through advanced preservation systems.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}